Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nkarta, Inc. | 46,000 | reported | 05 Jun 2025 | tx 6+134,211 |
| SpyGlass Pharma, Inc. | 27,400 | reported | 05 Feb 2026 | tx 1+27,400 |
| LENZ Therapeutics, Inc. | 13,500 | reported | 11 Jun 2025 | tx 2+40,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2026 | GRANT_AWARD | SpyGlass Pharma, Inc. | 27,400 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | LENZ Therapeutics, Inc. | 13,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Nkarta, Inc. | 46,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Nkarta, Inc. | 22,500 | 0.00 USD | deriv |
| 21 Mar 2024 | GRANT_AWARD | LENZ Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Nkarta, Inc. | 22,500 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Nkarta, Inc. | 16,000 | 0.00 USD | deriv |
| 13 Jun 2021 | GRANT_AWARD | Nkarta, Inc. | 16,511 | 0.00 USD | deriv |
| 09 Jul 2020 | GRANT_AWARD | Nkarta, Inc. | 10,700 | 0.00 USD | deriv |